Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes

Significance Human cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and in fetuses after congenital infection. gH/gL/gO and Pentamer are targets for neutralizing antibodies. We show that gO and UL128/UL130/UL131A bind to the same site on gH/gL through formation of a disulfide bond with gL-Cys144. The alternative use of this binding site by either gO or the ULs may provide a mechanism for cell tropism modulation. Our analysis reveals that gH/gL antigenic sites are conserved among gH/gL, gH/gL/gO, and Pentamer, whereas gH/gL/gO- and Pentamer-specific neutralizing antibody-binding sites are located in the gH/gL N terminus protrusion that contains the gO and the UL subunits. These data support the development of vaccines and antibody therapeutics against HCMV. Human cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and the leading viral cause of birth defects after congenital infection. The glycoprotein complexes gH/gL/gO and gH/gL/UL128/UL130/UL131A (Pentamer) are key targets of the human humoral response against HCMV and are required for HCMV entry into fibroblasts and endothelial/epithelial cells, respectively. We expressed and characterized soluble forms of gH/gL, gH/gL/gO, and Pentamer. Mass spectrometry and mutagenesis analysis revealed that gL-Cys144 forms disulfide bonds with gO-Cys351 in gH/gL/gO and with UL128-Cys162 in the Pentamer. Notably, Pentamer harboring the UL128-Cys162Ser/gL-Cys144Ser mutations had impaired syncytia formation and reduced interference of HCMV entry into epithelial cells. Electron microscopy analysis showed that HCMV gH/gL resembles HSV gH/gL and that gO and UL128/UL130/UL131A bind to the same site at the gH/gL N terminus. These data are consistent with gH/gL/gO and Pentamer forming mutually exclusive cell entry complexes and reveal the overall location of gH/gL-, gH/gL/gO-, and Pentamer-specific neutralizing antibody binding sites. Our results provide, to our knowledge, the first structural view of gH/gL/gO and Pentamer supporting the development of vaccines and antibody therapeutics against HCMV.

[1]  Peter W Mason,et al.  Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. , 2014, Vaccine.

[2]  S. Warming,et al.  Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109 , 2014, Proceedings of the National Academy of Sciences.

[3]  Huamin Tang,et al.  Human herpesvirus‐6A gQ1 and gQ2 are critical for human CD46 usage , 2014, Microbiology and immunology.

[4]  Amy S. Espeseth,et al.  Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine , 2013, Proceedings of the National Academy of Sciences.

[5]  F. Chen,et al.  Mutations in the Amino Terminus of Herpes Simplex Virus Type 1 gL Can Reduce Cell-Cell Fusion without Affecting gH/gL Trafficking , 2013, Journal of Virology.

[6]  Brent J. Ryckman,et al.  Comparative Analysis of gO Isoforms Reveals that Strains of Human Cytomegalovirus Differ in the Ratio of gH/gL/gO and gH/gL/UL128-131 in the Virion Envelope , 2013, Journal of Virology.

[7]  W. T. Saw,et al.  Regulation of Herpes Simplex Virus gB-Induced Cell-Cell Fusion by Mutant Forms of gH/gL in the Absence of gD and Cellular Receptors , 2013, mBio.

[8]  C. Mandl,et al.  Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. , 2013, Vaccine.

[9]  T. Jardetzky,et al.  The Large Groove Found in the gH/gL Structure Is an Important Functional Domain for Epstein-Barr Virus Fusion , 2013, Journal of Virology.

[10]  J. Shiver,et al.  Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. , 2012, Vaccine.

[11]  A. Herrmann,et al.  A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques , 2012, Journal of Virology.

[12]  R. Vandlen,et al.  Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin , 2012, Journal of Virology.

[13]  H. Blau,et al.  Structure–function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism , 2011, Proceedings of the National Academy of Sciences.

[14]  F. Baldanti,et al.  Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  J. Szustakowski,et al.  Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions. , 2011, Cell host & microbe.

[16]  David C. Johnson,et al.  Human Cytomegalovirus Glycoprotein gO Complexes with gH/gL, Promoting Interference with Viral Entry into Human Fibroblasts but Not Entry into Epithelial Cells , 2011, Journal of Virology.

[17]  T. Jardetzky,et al.  Fusing structure and function: a structural view of the herpesvirus entry machinery , 2011, Nature Reviews Microbiology.

[18]  U. Koszinowski,et al.  HCMV Spread and Cell Tropism are Determined by Distinct Virus Populations , 2011, PLoS pathogens.

[19]  T. Jardetzky,et al.  Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex , 2010, Proceedings of the National Academy of Sciences.

[20]  A. Sharff,et al.  Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody , 2010, Proceedings of the National Academy of Sciences.

[21]  R. Eisenberg,et al.  Cascade of Events Governing Cell-Cell Fusion Induced by Herpes Simplex Virus Glycoproteins gD, gH/gL, and gB , 2010, Journal of Virology.

[22]  R. Eisenberg,et al.  Crystal structure of the conserved herpesvirus fusion regulator complex gH–gL , 2010, Nature Structural &Molecular Biology.

[23]  Antonio Lanzavecchia,et al.  Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex , 2009, Journal of Virology.

[24]  T. Jardetzky,et al.  Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B , 2009, Proceedings of the National Academy of Sciences.

[25]  Brent J. Ryckman,et al.  HCMV gH/gL/UL128–131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptors , 2008, Proceedings of the National Academy of Sciences.

[26]  D. Lilleri,et al.  Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation. , 2008, Transplantation.

[27]  E. Heldwein,et al.  Entry of herpesviruses into mammalian cells , 2008, Cellular and Molecular Life Sciences.

[28]  W. Britt Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. , 2008, Current topics in microbiology and immunology.

[29]  G. Jahn,et al.  Cytomegalovirus cell tropism. , 2008, Current topics in microbiology and immunology.

[30]  S. Harrison,et al.  Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1 , 2006, Science.

[31]  Brent J. Ryckman,et al.  Human Cytomegalovirus Entry into Epithelial and Endothelial Cells Depends on Genes UL128 to UL150 and Occurs by Endocytosis and Low-pH Fusion , 2006, Journal of Virology.

[32]  T. Shenk,et al.  Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Longnecker,et al.  The Amino Terminus of Epstein-Barr Virus Glycoprotein gH Is Important for Fusion with Epithelial and B Cells , 2005, Journal of Virology.

[34]  T. Shenk,et al.  Human Cytomegalovirus UL131 Open Reading Frame Is Required for Epithelial Cell Tropism , 2005, Journal of Virology.

[35]  Markus Wagner,et al.  Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes , 2004, Journal of Virology.

[36]  R. Rabinovich,et al.  Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  H. Einsele,et al.  Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. , 1999, The Journal of general virology.

[38]  B. Klupp,et al.  Glycoprotein gL-Independent Infectivity of Pseudorabies Virus Is Mediated by a gD-gH Fusion Protein , 1999, Journal of Virology.

[39]  M. Huber,et al.  The Human Cytomegalovirus UL74 Gene Encodes the Third Component of the Glycoprotein H-Glycoprotein L-Containing Envelope Complex , 1998, Journal of Virology.

[40]  M. Huber,et al.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex , 1997, Journal of virology.

[41]  W. Britt,et al.  Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex , 1997, Journal of virology.

[42]  R. Pollard,et al.  Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication. , 1991, Antiviral research.

[43]  T. Compton,et al.  Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. , 1992, Virology.

[44]  H. Browne,et al.  The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro , 1992, Journal of virology.

[45]  M. Ho,et al.  Epidemiology of cytomegalovirus infections. , 1990, Reviews of infectious diseases.